Phanindra Antharam
Cardiovascular Disease · Provo, UTNPI 1811483381
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.3% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Abbott at 26.3% of the total.
Across 124 payments — averaging $50.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Amgen$793
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$543
- Inari Medical, Inc.$497
- Abiomed$492
- Medtronic$358
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,70791%
- Education$5449%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 31 | $1,645 |
| Amgen | 10 | $793 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $543 |
| Inari Medical, Inc. | 11 | $497 |
| Abiomed | 7 | $492 |
| Medtronic | 5 | $358 |
| Penumbra, Inc. | 2 | $277 |
| Sanofi | 2 | $233 |
| Shockwave Medical, Inc | 2 | $173 |
| Johnson & Johnson | 6 | $149 |
| Edwards Lifesciences | 5 | $128 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Impulse Dynamics (USA) Inc. | 1 | $122 |
| Philips North America LLC | 1 | $111 |
| Pfizer | 4 | $93 |
| Cardiva Medical, Inc. | 3 | $72 |
| AstraZeneca | 3 | $69 |
| Chiesi USA, Inc. | 4 | $66 |
| Kestra Medical Technology Services, Inc. | 2 | $53 |
| Stryker | 2 | $41 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $39 |
| Janssen Scientific Affairs, LLC | 2 | $34 |
| Boehringer Ingelheim | 1 | $34 |
| Teleflex LLC | 2 | $33 |
| Novartis | 2 | $32 |
| Heartflow, Inc. | 1 | $21 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$745
- ENSITE$539
- CT THROMBECTOMY SYSTEM KIT$321
- FLOWTRIEVER CATHETER, S$321
- Penumbra System$277
- OPTIMIZER$244
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$154
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$153
- FABRAZYME$150
- ENSITE PRECISION$145
- AMPLATZER AMULET$136
- Impella$130
- COREVALVE EVOLUT R$127
- CAMZYOS$125
- XARELTO$125
- (5027) Intact Vascular Undivided$111
- HawkOne$110
- Perclose ProStyle$106
- LifeVest$100
How this compares
$6,252 in reported general payments places this provider in the 70th percentile of 131 cardiovascular disease providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 26 | $116 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Provo
- Marvin AllenProvo$9K
- Stephen WilkinsonProvo$8K
- David PerryProvo$8K
- Hussein DaoudProvo$3K
- John RyanSalt Lake City$1.4M
- Robert FowlesSalt Lake City$611K
- Brian WhisenantMurray$416K
- Andrew BehuninDraper$192K
- Jeffrey OsbornSalt Lake City$69K
- James FangSalt Lake City$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.